James Symons
Conseiller Juridique Général chez Phrixus Pharmaceuticals, Inc.
Profil
James Symons is currently working as Vice President-Clinical & Regulatory Affairs at Phrixus Pharmaceuticals, Inc. He previously worked as Principal at Pfizer Inc. in 2005, Principal at The Jackson Laboratory, and Vice President-Clinical Development at Meditrina Pharmaceuticals, Inc. Dr. Symons holds a graduate and doctorate degree from the University of Michigan.
Postes actifs de James Symons
| Sociétés | Poste | Début |
|---|---|---|
Phrixus Pharmaceuticals, Inc.
 Phrixus Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Phrixus Pharmaceuticals, Inc. develops Carmeseal for DMD and for acute decompensated heart failure. It is repurposing Poloxamer for heart failure for which the only cure is heart transplantation. The company was founded by Thomas A. Collet and Bruce Markham in 2006 and is headquartered in Ann Arbor, MI. | Conseiller Juridique Général | - |
Anciens postes connus de James Symons
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2005 |
The Jackson Laboratory
 The Jackson Laboratory BiotechnologyHealth Technology The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME. | Corporate Officer/Principal | - |
Meditrina Pharmaceuticals, Inc.
 Meditrina Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meditrina Pharmaceuticals, Inc. operated as a clinical-stage pharmaceutical company that develops and commercializes medical therapies that threat women's reproductive system disorders, with a focus on gynecological and aromatase-mediated conditions with serious unmet medical needs such as endometriosis and uterine fibroids. The company was founded by Thomas A. Collet and Holly Vene in 2006 and was headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
Formation de James Symons
| University of Michigan | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Phrixus Pharmaceuticals, Inc.
Phrixus Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Phrixus Pharmaceuticals, Inc. develops Carmeseal for DMD and for acute decompensated heart failure. It is repurposing Poloxamer for heart failure for which the only cure is heart transplantation. The company was founded by Thomas A. Collet and Bruce Markham in 2006 and is headquartered in Ann Arbor, MI. | Health Technology |
The Jackson Laboratory
The Jackson Laboratory BiotechnologyHealth Technology The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME. | Health Technology |
Meditrina Pharmaceuticals, Inc.
Meditrina Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meditrina Pharmaceuticals, Inc. operated as a clinical-stage pharmaceutical company that develops and commercializes medical therapies that threat women's reproductive system disorders, with a focus on gynecological and aromatase-mediated conditions with serious unmet medical needs such as endometriosis and uterine fibroids. The company was founded by Thomas A. Collet and Holly Vene in 2006 and was headquartered in Ann Arbor, MI. | Health Technology |
